CPGShield resources · Claims
A cosmetic claim can do more than describe a benefit. In the United States, the wording can help establish the product's intended use—and intended use affects whether the product is regulated as a cosmetic, a drug or both.
That means a claim added during a late marketing review can create a classification problem even when the formula and package design have already been approved.
A claims review should happen before the words reach the label, website, advertisement, retailer listing, influencer brief or sales deck.
FDA describes cosmetics as products intended for cleansing, beautifying, promoting attractiveness or altering appearance. Drugs include products intended to diagnose, cure, mitigate, treat or prevent disease, as well as products intended to affect the structure or function of the body.
A product may be both a cosmetic and a drug. FDA gives anti-dandruff shampoo, fluoride toothpaste, antiperspirant deodorant and moisturizers marketed with sun-protection claims as examples of products that can fall into both categories.
The company cannot avoid the issue by using the word “cosmetic” or “cosmeceutical.” FDA says “cosmeceutical” has no meaning under the Federal Food, Drug, and Cosmetic Act.
For the related approval misconception, read Does FDA Preapprove Cosmetic Claims?.
Intended use is not established only by the front of the package. FDA identifies claims in labeling, advertising, websites and other promotional materials as possible evidence of intended use.
Build a complete claim inventory containing:
Copy the exact wording rather than summarizing it. Small verbs can matter.
Claims deserve closer review when they say or strongly imply that the product diagnoses, treats, cures, mitigates or prevents a disease or medical condition.
Examples that should trigger review include wording about treating acne, curing eczema, relieving psoriasis, eliminating dandruff, healing infection or reducing inflammation associated with a condition.
Context matters. “Makes dry skin look smoother” is different from “treats eczema,” even though both may appear on a moisturizer. A simple word substitution is not always enough; the product name, surrounding text, imagery, directions and testimonials can reinforce the same intended use.
Do not use this guide as a list of automatically safe replacement phrases. Review the complete presentation and the evidence supporting what remains.
A claim may also create drug implications when it says the product affects the body's structure or function.
FDA gives examples including restoring hair growth, reducing cellulite and regenerating cells. Other wording about changing biological processes, repairing tissue, altering melanin production or producing physiological effects should be evaluated in context.
This is particularly important for modern skin and hair marketing, where technical language can migrate from an ingredient study into a finished-product claim without anyone deciding whether the final wording changes the intended use.
A supplier may provide research about an ingredient. That does not automatically establish that the finished product produces the same result at the amount used, through the stated method of use, in the intended population.
For each objective claim, record:
CPGShield can organize the claim inventory, identify supported wording risks and show missing evidence. It does not independently determine that a study is scientifically adequate.
A brand may approve cautious package copy and then allow a retailer listing, advertisement or search description to introduce stronger language.
Compare every external listing with the approved claim inventory. Do not let a marketing agency, distributor or marketplace improvise therapeutic language to improve conversion.
The same rule applies to testimonials. Repeating or highlighting a customer's disease-treatment statement may create a different risk than leaving an unsolicited comment untouched. Escalate these situations for qualified review.
Some common product areas sit close to the cosmetic-drug boundary:
The answer is not to disguise a drug claim. The answer is to determine the intended use and applicable regulatory pathway before investing in the launch.
A practical workflow looks like this:
Do not approve a general concept such as “anti-aging story.” Approve the exact words the consumer will see.
Yes. FDA explains that intended use can be established by claims and other context. Classification does not depend only on whether the ingredients look familiar to the cosmetic industry.
FDA generally does not preapprove cosmetic claims. That does not remove the company's responsibility: cosmetic labeling must be truthful and not misleading, and drug claims can bring drug requirements into play.
No. CPGShield can identify claims that may need evidence, organize linked documents and flag missing support. It does not provide scientific validation, statistical review or professional legal approval.
Check your product free with CPGShield before approving the package, website and retailer copy. CPGShield screens supported claim patterns, keeps evidence gaps visible and shows detailed cited findings when the label review is unlocked.
Free cosmetic label compliance check. No demo required, no card. CPGShield LLC provides independent screening. We are not affiliated with, endorsed by, or acting for any retailer, brand, agency or organization we name.